Olema Pharmaceuticals, Inc. ( OLMA) - Stock Earnings
OLMA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 10, 2026, midnight | — / — | — | — / — | — |
OLMA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -42.2 million USD | — USD |
| 2025Q4 | -46.1 million USD | — USD |
| 2026Q1 | -53.1 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
OLMA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -96.7 million USD | — USD |
| 2024 | -129.5 million USD | — USD |
| 2025 | -162.5 million USD | — USD |
| 2026 Est. | — | — |
OLMA
Price: $11.70
52 week price:
Earnings Per Share: -2.03 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 106400
Market Capitalization: 1.1 billion